πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

6,867 results for β€œDe” Clear

  1. Inactivated HAV vaccine

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  2. Inactivated Hepatitis A vaccine (HAV)

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  3. Inactivated Polio Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  4. Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  5. Inactivated SARS-CoV-2 Vaccine (Vero cellοΌ‰

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  6. Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2 Infection

    approved mab active

    1 trial

  7. Injectable buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  8. Insulin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatitis, Acute

    approved small molecule active

    1 trial

  9. Intensive statin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule active

    1 trial

  10. Intranasal corticosteroids (INCS) combined with oral antihistamines (OAH) used for treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Allergic Rhinitis

    approved small molecule active

    1 trial

  11. Intranasal dexmedetomidine-esketamine

    The First People's Hospital of Lianyungang

    Adenotonsillectomy

    approved small molecule active

    1 trial

  12. Intrathecal (injected into the spinal fluid) DepoCyt

    Pacira Ireland Limited

    Meningeal Neoplasms

    approved small molecule completed

    1 trial

  13. Intravitreal Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule terminated

    2 trials

  14. Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Cystoid Macular Edema

    approved small molecule completed

    1 trial

  15. Intravitreal Aflibercept Injection (IAI)

    Regeneron UK Limited

    Age - Related Macular Degeneration (AMD)

    approved small molecule completed

    1 trial

  16. Intravitreal Aflibercept Injection 2mg

    Regeneron UK Limited

    Neovascular Age-related Macular Degeneration

    approved small molecule active

    2 trials

  17. Intravitreal aflibercept injection

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

  18. Investigational 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    2 trials

  19. Investigational live attenuated varicella vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab active

    4 trials

  20. Iohexol 300 mg I/ml solution for injection, MORPHINE (CHLORHYDRATE) RENAUDIN 1 mg/ml, solution injectable

    Tour Hekla

    Evaluation of the CKD-Epi score to identify a glomerular filtration threshold predictive of morphine failure at usual dosage, using a reference method for assessing renal function: iohexol clearance. All other aspects of the protocol are part of standard care practice.

    approved small molecule active

    1 trial

  21. Isatuximab, bortezomib, lenalidomide, dexamethason

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    approved small molecule active

    1 trial

  22. Isoniazid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tuberculosis, Pulmonary

    approved small molecule active

    1 trial

  23. Isoniazid Aminosalicylate Tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Reinfection Pulmonary Tuberculosis

    approved small molecule active

    1 trial

  24. Isotonic hydration fluid and recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources